
A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …

The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together …

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …

As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …

The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …

AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration …

Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …

AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …

French based pharmaceutical company Sanofi has announced it will ship its COVID-19 vaccine that is in development to the US …

President Donald Trump is set to announce that Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, and Gustave Perna, …

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …